Martin Shkreli, former hedge fund manager known as Pharma Bro, scolded finance personalities for not understanding accounting and defending Nvidia’s Q3 performance, which saw record revenue of $57.0B. He has previously argued that the company is undervalued and backed their investment in OpenAI. NVDA stock finished down 3.15% but has gained 23.82% in the last year.

read more